Curis
CRIS
#10277
Rank
S$30.13 M
Marketcap
S$0.75
Share price
-1.33%
Change (1 day)
-76.55%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -S$42.89 Million

According to Curis's latest financial reports the company's current earnings are S$11.65 Million. In 2024 the company made an earning of -S$54.47 Million, an increase over its 2023 earnings that were of -S$57.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$42.89 Million-21.26%
2024 -S$54.47 Million-5.77%
2023 -S$57.81 Million-13.1%
2022 -S$66.52 Million27.52%
2021 -S$52.16 Million65.09%
2020 -S$31.6 Million-9.1%
2019 -S$34.76 Million-4.73%
2018 -S$36.49 Million-41.95%
2017 -S$62.84 Million-14.37%
2016 -S$73.39 Million3.55%
2015 -S$70.87 Million271.52%
2014 -S$19.08 Million76.64%
2013 -S$10.8 Million
2011 -S$9.18 Million27.76%
2010 -S$7.18 Million-43.87%
2009 -S$12.8 Million-23.44%
2008 -S$16.71 Million56.66%
2007 -S$10.67 Million-16.71%
2006 -S$12.81 Million-36.92%
2005 -S$20.3 Million156.25%
2004 -S$7.93 Million-37.24%
2003 -S$12.63 Million-93.34%
2002 -S$0.19 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$12.97 B-31,404.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$11.87 B-28,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$78.8 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.19 B-2,990.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.37 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$31.53 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA